![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
20
Calao S.r.l. Milano It, based in U.S.A, is a pharmaceutical company.
One of their significant offerings is Isosorbide mononitrate, diluted, 70% and 80%, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R0-CEP 2001-329 - Rev 00
This Chemical Type CEP, issued on November 07, 2002, remains in force until January 06, 2004, ensuring its reliability within the pharmaceutical industry.
Substance Number 1118 associated with this CEP further emphasizes